Now playing Next Health news EU Policy. Agency chief seeks help from pharmacos with medicines shortages
Now playing Next Health news Americans turn to alternatives amid Ozempic shortage Approved in 2017 for adults with type 2 diabetes, Ozempic has now become a blockbuster weight loss drug. 04/12/2023
Now playing Next Business Sales skyrocket for weight-loss drug firm Novo Nordisk The Danish drugmaker expects double-digit growth to continue into 2024 as demand soars for obesity and diabetes medication. 02/11/2023
Now playing Next Health news Woman cured of bowel cancer in 6 months after receiving new drug A 42-year-old woman had no evidence of cancer after receiving the drug dostarlimab which is still in early trials for treatment of a rare form of colorectal cancer. 09/10/2023
Now playing Next world news Europe key to Syrian regime's amphetamine trade, finds report Europe has become the main transit route for Syrian Captagon tablets heading to the Middle East, according to the EMCDDA. 24/09/2023
Now playing Next Markets Novo Nordisk topples LVMH as Europe's most valuable company The Danish drugmaker has ended French luxury group LVMH's two-and-a-half-year reign as the most valuable company in Europe. 05/09/2023
Now playing Next Health news Weight-loss drug Wegovy could reduce risk of heart attack or stroke Danish pharmaceutical company Novo Nordisk says the medicine could reduce the risk of cardiovascular disease. But they’re also facing a lawsuit about severe side effects of its main ingredient. 09/08/2023
Now playing Next Health news New Alzheimer’s drug gets full approval from US regulators The treatment received conditional approval in January, but received full approval following a review of data from a further 1,800 patient study that showed the drug slowed cognitive decline by 5 months. 07/07/2023
Now playing Next Health news Move over, CBD: HHC is the new ‘legal cannabis’ causing concern After the boom of CBD, authorities worry about HHC, which can be ingested, smoked or vaped, with effects similar to those of cannabis. 25/05/2023
Now playing Next Healthcare Recreational cannabis goes on sale in some Swiss pharmacies A new pilot aims to assess the health effects of regulating cannabis supply in the Swiss city of Basel - and soon in Zurich, Geneva, and Lausanne. 30/03/2023
Now playing Next Health news Biden urges drug giants to slash insulin prices after Eli Lilly’s move "It’s a big deal, and it’s time for other manufacturers to follow," the US president said. 02/03/2023
Now playing Next Health news Cannabis start-ups blooming as Germany eyes legal recreational use German start-ups growing cannabis for medical use - legal in the country since 2016 - are booming. What impact will a move to recreational use have? 03/01/2022
Now playing Next Health news Can AI help detect the early stages of Alzheimer’s? The NHS is trialling a new AI-assisted tool that could help to diagnose mild cognitive impairment, a precursor to Alzheimer’s. 22/06/2021
Now playing Next USA Bayer to pay $10.9 billion to settle weedkiller cancer lawsuits German chemical giant Bayer said Wednesday it would pay up to $10.9 billion (9.6 billion euros) to settle a wave of lawsuits from Americans who allege its Roundup weedkiller caused their cancers. 24/06/2020
Now playing Next world news Early COVID-19 drug treatment trial shows promise, needs more study More than half of 53 severely ill COVID-19 patients treated with remdesivir showed improvement, but further information needed to determine its potential, experts say. 11/04/2020
Now playing Next world news Drugmaker launches lottery for life-saving gene therapy in babies Swiss drugmaker Novartis has launched an international lottery for its groundbreaking and extremely costly gene therapy Zolgensma, sparking both hope and outrage among patients’ families. 02/01/2020
Now playing Next USA Drug companies reach 11th-hour deal to settle US opioids lawsuit The US three dominant drug distributors and a big drugmaker reached a last-minute deal to settle a lawsuit over the opioid crisis just at the first federal trial was about to start. 21/10/2019
Now playing Next Hungary Hungarians raise €2m for sick toddler to access world's priciest drug People in Hungary have raised €2m for the family of a toddler with a rare genetic disorder to access the world’s most expensive drug 25/09/2019
Now playing Next France Mediator: Landmark trial opens in France over antidiabetic pill Servier Laboratories, the National Agency for the Safety of Medicines (ANSM) and 21 other defendants will face 2,684 plaintiffs. They allege that Mediator, marketed as an antidiabetic drug, has cost the lives of hundreds of patients. 23/09/2019
ADVERTISEMENT
ADVERTISEMENT